VAV-19

IC50 eleelAChE 0.177 +/- 0.05 MAO-B 6.06 +/- 0.69

General

Type : Monoamine-oxidase-inhibitor, Multitarget, Quinazoline, Piperazine, Alkyne

Chemical_Nomenclature : 4-(4-benzylpiperazin-1-yl)-2-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)quinazoline

Canonical SMILES : C1=CC=C2C(=C1)C(=NC(=N2)C3=CC=C(C(=C3)OC)OCC#C)N4CCN(CC4)CC5=CC=CC=C5

InChI : InChI=1S\/C29H28N4O2\/c1-3-19-35-26-14-13-23(20-27(26)34-2)28-30-25-12-8-7-11-24(25)29(31-28)33-17-15-32(16-18-33)21-22-9-5-4-6-10-22\/h1,4-14,20H,15-19,21H2,2H3

InChIKey : PXZCNYHBTYKZJQ-UHFFFAOYSA-N

Other name(s) :


MW : 464.566

Formula : C29H28N4O2

CAS_number :

PubChem :

UniChem : PXZCNYHBTYKZJQ-UHFFFAOYSA-N

Target

Families : VAV-19 ligand of proteins in family
ACHE

References (3)

Title : In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer's disease - Kumar_2025_Bioorg.Chem_155_108126
Author(s) : Kumar V , Jangid K , Kumar N , Mishra J , Arora T , Dwivedi AR , Kumar P , Bhatti JS , Parkash J
Ref : Bioorg Chem , 155 :108126 , 2025
Abstract :
PubMedSearch : Kumar_2025_Bioorg.Chem_155_108126
PubMedID: 39798452

Title : In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer's disease - Kumar_2025_Bioorg.Chem_155_108126
Author(s) : Kumar V , Jangid K , Kumar N , Mishra J , Arora T , Dwivedi AR , Kumar P , Bhatti JS , Parkash J
Ref : Bioorg Chem , 155 :108126 , 2025
Abstract :
PubMedSearch : Kumar_2025_Bioorg.Chem_155_108126
PubMedID: 39798452

Title : In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer's disease - Kumar_2025_Bioorg.Chem_155_108126
Author(s) : Kumar V , Jangid K , Kumar N , Mishra J , Arora T , Dwivedi AR , Kumar P , Bhatti JS , Parkash J
Ref : Bioorg Chem , 155 :108126 , 2025
Abstract :
PubMedSearch : Kumar_2025_Bioorg.Chem_155_108126
PubMedID: 39798452